DekaBank Deutsche Girozentrale - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$304,000
+275.3%
28,500
+23.9%
0.00%
+100.0%
Q4 2018$81,000
-73.4%
23,000
-19.3%
0.00%
-50.0%
Q3 2018$304,000
+42.1%
28,500
-1.7%
0.00%
+100.0%
Q2 2018$214,000
+21.6%
29,0000.0%0.00%0.0%
Q1 2018$176,000
-50.7%
29,000
-23.1%
0.00%
-66.7%
Q4 2017$357,0000.0%37,7000.0%0.00%0.0%
Q3 2017$357,000
-26.7%
37,7000.0%0.00%
-25.0%
Q2 2017$487,000
+17.6%
37,7000.0%0.00%0.0%
Q1 2017$414,000
+10.4%
37,700
-8.5%
0.00%0.0%
Q4 2016$375,000
-18.5%
41,200
+8.1%
0.00%
-20.0%
Q3 2016$460,000
-3.6%
38,1000.0%0.01%0.0%
Q2 2016$477,000
-3.0%
38,100
+22.9%
0.01%
-16.7%
Q1 2016$492,000
-54.1%
31,000
-15.1%
0.01%
-50.0%
Q4 2015$1,072,000
+4.9%
36,500
+1.7%
0.01%0.0%
Q3 2015$1,022,000
-16.8%
35,900
+5.0%
0.01%
-20.0%
Q2 2015$1,228,000
+28.9%
34,200
+108.5%
0.02%
+25.0%
Q1 2015$953,000
+23.3%
16,400
-11.1%
0.01%
+20.0%
Q4 2014$773,000
-1.0%
18,450
-8.4%
0.01%
-9.1%
Q3 2014$781,000
+27.2%
20,150
+2.5%
0.01%
+22.2%
Q2 2014$614,000
+13.1%
19,650
+50.0%
0.01%0.0%
Q1 2014$543,00013,1000.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders